Literature DB >> 3595662

Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia.

I Elovaara, J Palo, T Erkinjuntti, R Sulkava.   

Abstract

Serum concentrations of IgG, IgA, IgM, haptoglobin, transferrin, prealbumin and albumin quantitated nephelometrically in 22 patients with Alzheimer's disease (AD), 29 patients with multi-infarct dementia (MID) and their age-matched controls were normal. Cerebrospinal fluid (CSF) albumin and CSF/serum ratio for albumin were higher in AD and MID patients compared to controls, but no significant differences were found between AD and MID. Patients with MID had elevated CSF IgG, IgA, IgM and prealbumin levels compared to controls and to AD. An increased CSF IgG index was found in 5 MID patients but none of the AD patients. Thus, the blood-brain barrier permeability is often increased in MID as well as in AD. There is no increased intrathecal IgG synthesis in AD but it may occur in MID.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595662     DOI: 10.1159/000116341

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  8 in total

1.  Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future.

Authors:  Gene L Bowman; Joseph F Quinn
Journal:  Aging health       Date:  2008-02-01

Review 2.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

3.  Systemic immune system alterations in early stages of Alzheimer's disease.

Authors:  Rongzhen Zhang; Robert G Miller; Catherine Madison; Xia Jin; Ronald Honrada; Will Harris; Jonathan Katz; Dallas A Forshew; Michael S McGrath
Journal:  J Neuroimmunol       Date:  2013-02-04       Impact factor: 3.478

4.  Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study.

Authors:  Giovanni Zuliani; Michela Perrone Donnorso; Cristina Bosi; Angelina Passaro; Edoardo Dalla Nora; Amedeo Zurlo; Francesco Bonetti; Alessia F Mozzi; Claudio Cortese
Journal:  BMC Neurol       Date:  2011-10-04       Impact factor: 2.474

Review 5.  Mechanisms of neuroinflammation in hydrocephalus after intraventricular hemorrhage: a review.

Authors:  Katherine G Holste; Fan Xia; Fenghui Ye; Richard F Keep; Guohua Xi
Journal:  Fluids Barriers CNS       Date:  2022-04-01

6.  Increased plasma and brain immunoglobulin A in Alzheimer's disease is lost in apolipoprotein E ε4 carriers.

Authors:  Dovilė Pocevičiūtė; Cristina Nuñez-Diaz; Bodil Roth; Shorena Janelidze; Andreas Giannisis; Oskar Hansson; Malin Wennström
Journal:  Alzheimers Res Ther       Date:  2022-08-26       Impact factor: 8.823

7.  Human serum albumin can regulate amyloid-β peptide fiber growth in the brain interstitium: implications for Alzheimer disease.

Authors:  Helen F Stanyon; John H Viles
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

8.  Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation.

Authors:  L M Tai; K A Holloway; D K Male; A J Loughlin; I A Romero
Journal:  J Cell Mol Med       Date:  2009-04-02       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.